A detailed history of Mcf Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Mcf Advisors LLC holds 277 shares of BSX stock, worth $25,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
277
Previous 140 97.86%
Holding current value
$25,226
Previous $10,000 130.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$72.96 - $84.0 $9,995 - $11,508
137 Added 97.86%
277 $23,000
Q1 2024

Apr 16, 2024

BUY
$57.6 - $68.62 $691 - $823
12 Added 9.38%
140 $9,000
Q3 2023

Oct 19, 2023

BUY
$50.19 - $54.68 $3,312 - $3,608
66 Added 106.45%
128 $6,000
Q1 2022

May 05, 2022

BUY
$40.9 - $45.1 $2,535 - $2,796
62 New
62 $2,000
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $2,360 - $2,781
-62 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $2,556 - $2,844
62 New
62 $3,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.